← FDA Drug Approvals (Drugs@FDA)

COMETRIQ

NDA · New Drug Application · Sponsor: EXELIXIS · Approved 2012-11-29

Drug application

FDA Application #

NDA203756

Application type

New Drug Application

Brand name

COMETRIQ

Generic name

CABOZANTINIB

Active ingredients

CABOZANTINIB S-MALATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

EXELIXIS

Manufacturer

Exelixis, Inc.

First approval

2012-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown